Jean Stéphenne Overview

  • Investor Type
  • Angel

  • Investments
  • 3

  • Portfolio
  • 2

Jean Stéphenne General Information

Description

Mr. Jean Stéphenne is an Angel Investor. He has served as Investment Committee Member at Mérieux Equity Partners. He holds a degree in chemical engineering and agricultural sciences from the Faculty of Agricultural Sciences of Gembloux, as well as a degree in management from the Catholic University of Louvain. He began his career at SmithKline-Rit, where he rose all the ranks, to become Chairman and Chief Executive Officer until April 2012. Since then, he has been Special Advisor to the CEO of GSK. He has been a Director of Groupe Bruxelles Lambert since 2003.

Business Details

Primary Investor Type
Angel (individual)

Jean Stéphenne Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
N-SIDE 29-Mar-2021 Angel (individual) 000.00 IT Consulting and Outsourcing Generating Revenue 0000 00é0000
Bioxodes 01-Jan-2015 00000 00000 00.00 Drug Discovery Clinical Trials - Phase 1 0000 00é0000
Bioxodes 26-Nov-2013 0000 00000 00.000 Drug Discovery Clinical Trials - Phase 1 0000 00é0000

Jean Stéphenne Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Jean Stéphenne Team (1)

Name Title Deals Funds Boards Office
Jean Stéphenne Angel Investor 0

Jean Stéphenne FAQs

  • Who is Jean Stéphenne?

    Jean Stéphenne is an angel Investor who has made 3 investments.

  • What kind of investor is Jean Stéphenne?

    Jean Stéphenne is an angel investor.

  • What does Jean Stéphenne do?

    As an angel investor, Jean Stéphenne invests personal money into promising companies, typically in exchange for equity.

  • What has Jean Stéphenne invested in?

    Jean Stéphenne has made numerous investments in companies like N-SIDE and Bioxodes within the IT Consulting and Outsourcing and Drug Discovery industries.

  • What has Jean Stéphenne invested in recently?

    Jean Stéphenne's latest investment was on 29-Mar-2021 in N-SIDE, a company within the IT Consulting and Outsourcing industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »